A clinical trial to study the efficacy of an ayurvedic drug in cognitively impaired elders
Phase 2
Recruiting
- Conditions
- Health Condition 1: null- Mild cognitively impaired
- Registration Number
- CTRI/2017/10/010095
- Lead Sponsor
- Sri Dharmasthala Manjunatheshwara college of Ayurveda and hospital BM road Taneeruhalla Hassan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients of above 50 years of age are assessed under MoCA Scale and those who are diagnosed with Mild Cognitive Impairment are included under study.
2) Irrespective of gender and socio-economic status.
3) Diagnosed patients who are ready to sign the informed consent form.
Exclusion Criteria
1) Patients who have reduced cognitive functions as a result of trauma, surgery and due to any other organic lesions etc.
2) Patients suffering from acute and chronic renal failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Kushmanda (Benincasa hispida) Swarasa's effects on mild cognitive impairment (MCI)?
How does Kushmanda Swarasa compare to cholinesterase inhibitors in treating age-related MCI?
Are there specific biomarkers that correlate with Kushmanda Swarasa efficacy in elderly MCI patients?
What adverse events are associated with Kushmanda Swarasa in phase II trials for cognitive disorders?
What are potential combination therapies involving Kushmanda Swarasa for neurodegenerative conditions?